KRISTINA WHITTEN: Open Payments
NPI 1487251617 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 50 payments from 16 companies in 2025. Trend: 2023 $830 · 2024 $649 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $141 |
| BridgeBio Pharma, Inc. | 5 | $110 |
| Amgen Inc. | 6 | $95 |
| Alnylam Pharmaceuticals Inc. | 3 | $73 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Novo Nordisk Inc | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| Philips North America LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: Kerendia, Attruby, REPATHA, AMVUTTRA, INJECTAFER, LEQVIO, VERQUVO, Wegovy.
Industry payments across TN — which companies pay providers there.
